logo
logo

Biom X Inc. announced it raised $3 Million in an initial filing from an offering of $5 Million

Jan 04, 2022over 3 years ago

Amount Raised

$3 Million

Round Type

seed

IsraelBiotechnology Research

Company Information

Company

BiomX Inc.

Location

22 EINSTEIN ST., FLOOR 4

Israel

About

BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Related People